Overview
Sirolimus for Retinal Astrocytic Hamartoma
Status:
Recruiting
Recruiting
Trial end date:
2021-12-31
2021-12-31
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
A single patient study using intravitreal Sirolimus to treat a patient with multiple retinal astrocytic hamartomas (RAH) of both eyes.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
The Hospital for Sick ChildrenTreatments:
Sirolimus
Criteria
Single case diagnosed with multiple retinal astrocytic hamartomas (RAH) of both eyes withimminent threat to vision.